NEW YORK (GenomeWeb News) – Molecular data interpretation firm N-of-One today announced a deal with Fox Chase Cancer Center to provide interpretation and treatment strategy services for genome sequencing and testing.

Under the terms of the deal, N-of-One will analyze the molecular profiles and mutations identified in patients' cancers and provide treatment strategy profiles, including data on approved and investigational therapies, to Fox Chase physicians.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.